29 janvier 2016

ORPHELIA Pharma joins MEDICEN Paris Région
29 janvier 2016

ORPHELIA Pharma joins MEDICEN Paris Région as an active member. The competitive cluster MEDICEN Paris Région, which is dedicated to new technologies and innovative therapies, and of SMEs, contributes since its creation in 2006 to boost growth and influence of the Ile-de-France health sector. Please consult: http://www.medicen.org/  
[ Read more ]
9 octobre 2015

ORPHELIA Pharma strengthens its development operations
9 octobre 2015

ORPHELIA Pharma, a French company specialized in the development and commercialization of pediatric medicines, today announced that initiative Octalfa joined the company as a minority shareholder, director and operating partner.
[ Read more ]
1 octobre 2015

TargeOn SAS to become ORPHELIA Pharma SA
1 octobre 2015

TargeOn SAS, a French company specialized in the development and commercialization of pediatric medicines, today announced that the company will be renamed ORPHELIA Pharma SA, effective October 9th, 2015.
[ Read more ]
24 septembre 2015

ORPHELIA Pharma at Bio-Europe, Munich – Germany
24 septembre 2015

ORPHELIA Pharma will be present in Munich on November, 2 to 4 for the 21st annual BIO-Europe Congress. This event is the Europe’s largest partnering conference serving the global biotechnology industry. Do not hesitate to contact us to meet at this occasion. More info at: http://www.ebdgroup.com/bioeurope/index.php and http://www.partneringone.com Visit us at: http://www.orphelia-pharma.eu
[ Read more ]